Bioten Co., Ltd. (XKON:289170)

Bioten Statistics

Total Valuation

Bioten has a market cap or net worth of KRW 13.91 billion.

Market Cap	13.91B
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Bioten has 3.58 million shares outstanding.

Current Share Class	3.58M
Shares Outstanding	3.58M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	15.80%
Float	n/a

Valuation Ratios

The trailing PE ratio is 11.82.

PE Ratio	11.82
Forward PE	n/a
PS Ratio	1.30
PB Ratio	5.79
P/TBV Ratio	7.38
P/FCF Ratio	6.69
P/OCF Ratio	6.38
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 1.02.

Current Ratio	1.15
Quick Ratio	0.95
Debt / Equity	1.02
Debt / EBITDA	1.30
Debt / FCF	1.18
Interest Coverage	16.22

Financial Efficiency

Return on equity (ROE) is 54.09% and return on invested capital (ROIC) is 23.99%.

Return on Equity (ROE)	54.09%
Return on Assets (ROA)	16.81%
Return on Invested Capital (ROIC)	23.99%
Return on Capital Employed (ROCE)	52.38%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.62
Inventory Turnover	8.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -58.22% in the last 52 weeks. The beta is 0.08, so Bioten's price volatility has been lower than the market average.

Beta (5Y)	0.08
52-Week Price Change	-58.22%
50-Day Moving Average	3,721.90
200-Day Moving Average	4,053.43
Relative Strength Index (RSI)	53.08
Average Volume (20 Days)	339

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioten had revenue of KRW 10.71 billion and earned 1.02 billion in profits. Earnings per share was 329.00.

Revenue	10.71B
Gross Profit	3.92B
Operating Income	1.78B
Pretax Income	1.02B
Net Income	1.02B
EBITDA	1.88B
EBIT	1.78B
Earnings Per Share (EPS)	329.00

Balance Sheet

The company has 2.45 billion in cash and 2.45 billion in debt, giving a net cash position of 7.02 million or 1.96 per share.

Cash & Cash Equivalents	2.45B
Total Debt	2.45B
Net Cash	7.02M
Net Cash Per Share	1.96
Equity (Book Value)	2.40B
Book Value Per Share	722.56
Working Capital	551.51M

Cash Flow

In the last 12 months, operating cash flow was 2.18 billion and capital expenditures -100.60 million, giving a free cash flow of 2.08 billion.

Operating Cash Flow	2.18B
Capital Expenditures	-100.60M
Free Cash Flow	2.08B
FCF Per Share	581.47

Margins

Gross margin is 36.65%, with operating and profit margins of 16.60% and 9.56%.

Gross Margin	36.65%
Operating Margin	16.60%
Pretax Margin	9.56%
Profit Margin	9.56%
EBITDA Margin	17.60%
EBIT Margin	16.60%
FCF Margin	19.43%

Dividends & Yields

Bioten does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7.36%
FCF Yield	14.95%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioten has an Altman Z-Score of 1.31 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.31
Piotroski F-Score	4